Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cancers|August 10, 2024
Growth Hormone Upregulates Melanoma Drug Resistance and Migration via Melanoma-Derived ExosomesPrateek Kulkarni, Reetobrata Basu, Taylor Bonn, et al.
Archives of Endocrinology and Metabolism|January 16, 2020
New insights of growth hormone (GH) actions from tissue-specific GH receptor knockouts in miceEdward O List, Darlene E Berryman, Elizabeth A Jensen, et al.
Vitamins and Hormones|September 17, 2023
Growth hormone receptor gene disruptionEdward O List, Silvana Duran-Ortiz, Prateek Kulkarni, et al.
The Journal of Biological Chemistry|March 28, 2021
A novel peptide antagonist of the human growth hormone receptorReetobrata Basu, Khairun Nahar, Prateek Kulkarni, et al.
Journal for Immunotherapy of Cancer|April 15, 2026
Regional immunosuppression and associated systemic markers in focally relapsed sarcomatoid mesothelioma: case reportHely Ollila, Prateek Kulkarni, Hyojin Kim, et al.
The Journal of Biological Chemistry|July 13, 2023
Structure and function of a dual antagonist of the human growth hormone and prolactin receptors with site-specific PEG conjugatesReetobrata Basu, Rich Brody, Uday Sandbhor, et al.
Endocrinology|June 20, 2020
The Effects of 20-kDa Human Placental GH in Male and Female GH-deficient Mice: An Improved Human GH?Edward O List, Darlene E Berryman, Reetobrata Basu, et al.
Aging Cell|November 23, 2021
Growth hormone receptor gene disruption in mature-adult mice improves male insulin sensitivity and extends female lifespanSilvana Duran-Ortiz, Edward O List, Yuji Ikeno, et al.
International Journal of Molecular Sciences|July 13, 2024
Growth Hormone Receptor Antagonist Markedly Improves Gemcitabine Response in a Mouse Xenograft Model of Human Pancreatic CancerReetobrata Basu, Prateek Kulkarni, Deborah Swegan, et al.
Pageof 2